{"id":"prtimes-72333","slug":"prtimes-72333","canonical_name":"ジェイファーマ株式会社","entity_type":"business","schema_org_type":"Organization","canonical_url":"https://ida.idaeo.ai/prtimes-72333","sameAs":["https://www.j-pharma.com/"],"public_ids":{"sameAs":["https://www.j-pharma.com/"],"citation":{"v":1,"faq":[{"a":{"en":"J-Pharma Co., Ltd. registered an investigator-initiated clinical trial on jRCT for its LAT1 inhibitor nanvuranlat in biliary tract cancer, in collaboration with Cancer Institute Hospital, evaluating combination with immune checkpoint inhibitors.","ja":"ジェイファーマ株式会社は、LAT1阻害剤「ナンブランラト」の胆道がんに対する医師主導臨床試験をjRCTに登録した。がん研究会有明病院と連携し、免疫チェックポイント阻害剤との併用効果を検証する。","ko":"ジェイファーマ株式会社의 IDA 공개 프로필입니다.","zh":"J-Pharma 株式會社宣布，其 LAT1 抑制劑 nanvuranlat 用於膽道癌的醫師主導臨床試驗已在 jRCT 註冊，與癌症研究會有明醫院合作，評估與免疫檢查點抑制劑的合併療法。"},"q":{"en":"What is ジェイファーマ株式会社?","ja":"ジェイファーマ株式会社とは？","ko":"ジェイファーマ株式会社은(는) 어떤 곳인가요?","zh":"ジェイファーマ株式会社是什麼？"}}],"kind":"business","title":"ジェイファーマ株式会社｜企業情報・公式リンク","booking":[],"summary":{"en":"J-Pharma Co., Ltd. registered an investigator-initiated clinical trial on jRCT for its LAT1 inhibitor nanvuranlat in biliary tract cancer, in collaboration with Cancer Institute Hospital, evaluating combination with immune checkpoint inhibitors.","ja":"ジェイファーマ株式会社は、LAT1阻害剤「ナンブランラト」の胆道がんに対する医師主導臨床試験をjRCTに登録した。がん研究会有明病院と連携し、免疫チェックポイント阻害剤との併用効果を検証する。","ko":"ジェイファーマ株式会社의 IDA 공개 프로필입니다.","zh":"J-Pharma 株式會社宣布，其 LAT1 抑制劑 nanvuranlat 用於膽道癌的醫師主導臨床試驗已在 jRCT 註冊，與癌症研究會有明醫院合作，評估與免疫檢查點抑制劑的合併療法。"},"modified":"2026-06-14","published":"2026-06-14","info_table":[],"description":"ジェイファーマ株式会社は、LAT1阻害剤「ナンブランラト」の胆道がんに対する医師主導臨床試験をjRCTに登録した。がん研究会有明病院と連携し、免疫チェックポイント阻害剤との併用効果を検証する。"},"corp_src":"kokuzei_unique","flagged_at":"2026-06-17","flagged_corp":"6011101043476","anchor_method":"websearch+gbizinfo+curl200","registry_name":"ジェイファーマ株式会社","jp_corp_number":"6011101043476","anchor_found_at":"2026-06-18","name_number_gate":"pass"},"owner_published":{"available":false,"published_at":null,"source":null},"freshness":{"observed_at":"2026-06-18T03:47:24.082Z","expires_at":null,"is_stale":null,"source":"entity.last_updated"},"provenance":{"source":"tqaeo.public.ida_entities_public.public_ids.owner_published","generated_at":"2026-09-03T12:33:38.444Z","owner_published_source":null,"contract_version":"owner-published-freshness/v1","sameAs_policy":"owner_published_does_not_upgrade_verification_level"},"verification_level":"verified","edge_summary":{"total_edges":0,"sameAs_eligible_edges":0,"strongest_edge_tier":null,"public_id_count":1},"last_updated":"2026-06-18T03:47:24.082Z"}